Bacterial infections:

Indications for: SYNERCID

Treatment of complicated skin and skin structure infections due to S. aureus (methicillin-susceptible) or S. pyogenes.

Adult Dosage:

Give by IV infusion over 60mins. ≥16yrs: 7.5mg/kg every 12hrs for at least 7 days.

Children Dosage:

<16yrs: not established; doses of 7.5 mg/kg every 8hrs or 12hrs have been used in a limited number of children under emergency-use conditions (see full labeling).

SYNERCID Warnings/Precautions:

Hepatic insufficiency. Pregnancy. Nursing mothers.

SYNERCID Classification:


SYNERCID Interactions:

Avoid concomitant drugs known to prolong the QT interval. Potentiates CYP3A4 substrates (eg, midazolam, nifedipine, cisapride, carbamazepine, vinca alkaloids, taxanes, steroids, NNRTIs, protease inhibitors, statins); monitor esp. those with narrow therapeutic window (eg, cyclosporine, tacrolimus). May affect digoxin.

Adverse Reactions:

Inj site reactions, arthralgia, myalgia, GI upset, thrombophlebitis, rash, headache, pruritus; C. difficile-associated diarrhea.

How Supplied:

Single-dose vials—10